90.08
price down icon0.44%   -0.40
after-market Handel nachbörslich: 90.90 0.82 +0.91%
loading
Schlusskurs vom Vortag:
$90.48
Offen:
$89.415
24-Stunden-Volumen:
962.29K
Relative Volume:
0.71
Marktkapitalisierung:
$7.39B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.72M
KGV:
-45.04
EPS:
-2
Netto-Cashflow:
$-103.81M
1W Leistung:
-5.29%
1M Leistung:
+7.11%
6M Leistung:
+86.89%
1J Leistung:
+482.66%
1-Tages-Spanne:
Value
$89.10
$93.39
1-Wochen-Bereich:
Value
$89.10
$97.44
52-Wochen-Spanne:
Value
$15.15
$99.01

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
Firmenname
Verona Pharma Plc Adr
Name
Telefon
011-44-0-2032834200
Name
Adresse
3 MORE LONDON RIVERSIDE, LONDON
Name
Mitarbeiter
209
Name
Twitter
@VeronaPharma
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
VRNA's Discussions on Twitter

Vergleichen Sie VRNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VRNA
Verona Pharma Plc Adr
90.08 7.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-28 Eingeleitet TD Cowen Buy
2025-04-21 Eingeleitet Cantor Fitzgerald Overweight
2025-01-10 Eingeleitet ROTH MKM Buy
2024-10-03 Eingeleitet Wells Fargo Overweight
2023-05-22 Fortgesetzt Jefferies Buy
2022-09-19 Fortgesetzt Wedbush Outperform
2022-08-26 Eingeleitet Piper Sandler Overweight
2021-09-13 Eingeleitet H.C. Wainwright Buy
2020-08-25 Eingeleitet Jefferies Buy
2020-08-10 Eingeleitet Canaccord Genuity Buy
2019-04-18 Eingeleitet BTIG Research Buy
Alle ansehen

Verona Pharma Plc Adr Aktie (VRNA) Neueste Nachrichten

pulisher
Jun 10, 2025

Verona Pharma: A Blockbuster Franchise In The Making - Seeking Alpha

Jun 10, 2025
pulisher
Jun 05, 2025

Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today - Barchart.com

Jun 05, 2025
pulisher
Jun 02, 2025

21 Best-Performing Small-Cap Stocks for June 2025 - NerdWallet

Jun 02, 2025
pulisher
May 30, 2025

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data - Benzinga

May 30, 2025
pulisher
May 29, 2025

Verona Pharma ADR Surges, Matches Key 52-Week High: What’s Fueling the Rally? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Verona Pharma stock soars to all-time high of $77.08 By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 23, 2025

FDA Approves GSK's Nucala for Expanded Use in COPD - Zacks Investment Research

May 23, 2025
pulisher
May 20, 2025

Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart

May 20, 2025
pulisher
May 20, 2025

Verona Pharma stock soars to all-time high of $74.36 By Investing.com - Investing.com UK

May 20, 2025
pulisher
May 08, 2025

Market Update: Verona Pharma Plc ADR (VRNA) Sees Negative Movement, Closing at 69.14 - DWinneX

May 08, 2025
pulisher
May 08, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA): An Enticing Stock To Watch - Stocksregister

May 08, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Verona Pharma director Vikas Sinha sells $178,416 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 - Investing.com

May 01, 2025
pulisher
May 01, 2025

Verona Pharma Plc ADR (VRNA)’s Market Momentum: Closing Strong at 72.07, Down -1.56 - DWinneX

May 01, 2025
pulisher
Apr 30, 2025

What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Verona Pharma Plc ADR [VRNA] Stock trading around $73.21 per share: What’s Next? - dbtnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

VRNA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Watch this stock’s price performance: Verona Pharma Plc ADR (NASDAQ:VRNA) - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Verona Pharma ADR earnings beat by $0.05, revenue topped estimates - Investing.com UK

Apr 29, 2025
pulisher
Apr 28, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Could Soar To Much Higher Prices In Coming Months - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 28, 2025

TD Cowen starts Verona Pharma stock at Buy, sets $100 target - Investing.com

Apr 28, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Verona Pharma Plc ADR (VRNA) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Is Astrazeneca plc ADR (AZN) positioned for future growth? - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Plc ADR [VRNA] Records 50-Day SMA of $62.73 - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Tencent Music Entertainment Group ADR [TME] Officer makes an insider purchase of 1,036,363 shares worth 14.87 million. – Knox Daily - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

TAL Education Group ADR [TAL] Officer makes an insider purchase of 24,041 shares worth 0.28 million. - knoxdaily.com

Apr 25, 2025
pulisher
Apr 24, 2025

Ratios Uncovered: Breaking Down Verona Pharma Plc ADR (VRNA)’s Trailing Twelve Months Metrics - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Verona Pharma Plc ADR (VRNA) is a good investment, but the stock may be overvalued - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

What is the investor’s view on Marriott Vacations Worldwide Corp (VAC)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Was Phathom Pharmaceuticals Inc (PHAT)’s session last reading good? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Zentalis Pharmaceuticals Inc (ZNTL) deserves deeper analysis - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Financial Health Report: Alamos Gold Inc (AGI)’s Ratios Tell a Tale - DWinneX

Apr 24, 2025
pulisher
Apr 21, 2025

Cantor Fitzgerald sets $80 target on Verona Pharma stock By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 17, 2025

Investing in Verona Pharma Plc ADR (VRNA) might be a great opportunity, but the stock is a bit undervalued - uspostnews.com

Apr 17, 2025
pulisher
Apr 07, 2025

Verona Pharma Plc ADR [VRNA] Rickard Kathleen A. sells 79,264 Shares for $0.66 million - knoxdaily.com

Apr 07, 2025
pulisher
Apr 03, 2025

Verona Pharma Plc ADR [VRNA] Chief Medical Officer makes an insider purchase of 79,264 shares worth 0.66 million. - knoxdaily.com

Apr 03, 2025
pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Verona Pharma secures $450 million credit facility on better terms - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Xeris Biopharma reshuffles board, appoints new director - Investing.com

Mar 28, 2025
pulisher
Mar 25, 2025

The growth track for Cracker Barrel Old Country Store Inc (CBRL) has changed recently - SETE News

Mar 25, 2025
pulisher
Mar 18, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Up 298.80% This Year: What Is Going To Happen Next - Stocks Register

Mar 18, 2025
pulisher
Mar 14, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 - Investing.com India

Mar 14, 2025
pulisher
Mar 13, 2025

Verona Pharma’s chief medical officer sells shares worth $661,941 By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 10, 2025

Keeping an Eye on Gilead Sciences, Inc (GILD) After Insider Trading Activity - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

McEwen Mining Inc (MUX) Becoming More Attractive for Investors - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Morgan Stanley Upgrades Solaredge Technologies Inc (SEDG) to an Equal-weight from an Underweight - Knox Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Verona Pharma at Leerink Global Healthcare: Eutuvera’s Promising Launch By Investing.com - Investing.com UK

Mar 10, 2025
pulisher
Feb 28, 2025

Earnings call transcript: Verona Pharma Q4 2024 beats EPS & revenue forecasts By Investing.com - Investing.com South Africa

Feb 28, 2025

Finanzdaten der Verona Pharma Plc Adr-Aktie (VRNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Verona Pharma Plc Adr-Aktie (VRNA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Fisher Andrew
General Counsel
Jun 16 '25
Sale
11.53
80,000
922,000
359,999
Hahn Mark W
Chief Financial Officer
Jun 11 '25
Sale
11.40
400,000
4,560,360
12,278,992
ZACCARDELLI DAVID
President and CEO
Jun 11 '25
Sale
11.40
400,000
4,560,520
13,190,168
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):